Minireviews
Copyright ©The Author(s) 2021.
World J Hepatol. Jul 27, 2021; 13(7): 763-773
Published online Jul 27, 2021. doi: 10.4254/wjh.v13.i7.763
Table 1 Estimated prevalence of nonalcoholic fatty liver disease in the general United States population (three main Race-ethnicities)
Ref.Whites
Blacks
Hispanics
No.
Denom
Percentage
No.
Denom
Percentage
No.
Denom
Percentage
Rich et al[8]244542005100.123625547900.075125405910.13
Kallwitz et al[7]169193420.18
Zou et al[14]222943410.5153828330.19168638860.43
Lim et al[20]824000.2492970.161803770.48
Foster et al[16]18912440.151069920.102087750.27
Total269542064950.134318589120.078890549710.16
Table 2 Prevalence of metabolic syndrome and its components in African Americans vs Hispanics[17]

AA
H
P value
Percentage MetS1933< 0.0001
% Diabetes1717NS
Mean HDL5347< 0.0001
Mean TG107160< 0.0001
Mean BMI31290.008
Table 3 Percentage of patients with the PNPLA3 G allele polymorphism and FIB-4 > 2.67[3]

% PNPLA3-G allele
% Suspected NAFLD
% FIB-4 > 2.67
Mexican American52210.4
South American51200.3
Central American48230.9
Puerto-Rican35162.0
Cuban28161.8
Dominican22130.5